Stock listing
Jiangsu Recbio Technology Co., Ltd. Class H
Selected listing: 2179 · HKEX · HKD · HK
Jiangsu Recbio Technology Co., Ltd. Class H (HKEX:2179), Commercial Services. Latest release Oct 2, 2026: Monthly Return of Equity Issuer on Movements…
- Ticker
- HKEX:2179
- Asset type
- Stock
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- HKEX
- Currency
- HKD
About Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. Class H is a public company listed on the Hong Kong Stock Exchange under the ticker 2179. Recbio focuses on the development and commercialization of innovative vaccines.
Latest news from Jiangsu Recbio Technology Co., Ltd. Class H
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 2, 2026
Jiangsu Recbio Technology Says New Drug Application For REC610 Shingles Vaccine Accepted By NMPA
December 29, 2025
Jiangsu Recbio Technology Says Liu Yong Resigned As Chair
December 23, 2025
Jiangsu Recbio Technology Says Li Bu Resigned As Executive Director
December 1, 2025
Research Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. Class H company profile
View the public company page for Jiangsu Recbio Technology Co., Ltd. Class H on 6ix.
Jiangsu Recbio Technology Co., Ltd. Class H news
Read company news and market updates connected to Jiangsu Recbio Technology Co., Ltd. Class H.
Jiangsu Recbio Technology Co., Ltd. Class H investor events
Find investor webinars, events, and replay context for Jiangsu Recbio Technology Co., Ltd. Class H.
Alternate listings
A3EHWQ:LSX
DE · EUR
Alternate listing for Jiangsu Recbio Technology Co., Ltd. Class H; the primary context on this page is 2179:HKEX.
G93:FWB
DE · EUR
Alternate listing for Jiangsu Recbio Technology Co., Ltd. Class H; the primary context on this page is 2179:HKEX.
A3EHWQ:LS
DE · EUR
Alternate listing for Jiangsu Recbio Technology Co., Ltd. Class H; the primary context on this page is 2179:HKEX.